Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » MHTX - Licenses Fuel Cell Technology To Chinese Company! - NEW PR

 - UBBFriend: Email this page to someone!    
Author Topic: MHTX - Licenses Fuel Cell Technology To Chinese Company! - NEW PR
gpmac
Member


Rate Member
Icon 14 posted      Profile for gpmac     Send New Private Message       Edit/Delete Post   Reply With Quote 
EXCELLLENT NEW FROM THE FUEL CELL FRONT!

Manhattan Scientifics Licenses Mid-Range Fuel Cell Technology

February 03, 2004 09:33:55 (ET)


NEW YORK, Feb 03, 2004 /PRNewswire via COMTEX/ -- Manhattan Scientifics, Inc. (MHTX) announced today that it has licensed its mid-range (NovArs) fuel cell technology to a Singapore company with manufacturing in China. The contract gives the licensee non-exclusive rights to produce and sell fuel cell engines based on the NovArs technology owned by Manhattan Scientifics. The agreement involves an upfront payment, royalty and other forms of consideration.

Manhattan Scientifics' COO Jack Harrod said, "This is a positive step in our efforts to provide low-cost fuel cells systems to Chinese, Asian and other worldwide markets. We believe this relationship provides a basis for building future shareholder value." The technology was licensed last May to Ballard Power Systems of Canada on a non-exclusive basis.

About Manhattan Scientifics

Manhattan Scientifics, Inc. (www.mhtx.com) is a technology development company working in the fields of alternative energy and computer touch haptics technology. The company's facilities are located in Los Alamos and Albuquerque, New Mexico and New York City. Copies of Manhattan Scientifics' press releases, current quotes, stock charts and other information for investors may be found on the websites www.hawkassociates.com and www.hawkmicrcocaps.com.

The foregoing press release contains forward-looking statements (including expectation of future events), which are subject to risks, and uncertainty, which may be beyond the company's control. Actual results could differ materially for many reasons including but not limited to completion of R&D and successful commercialization of products/services, patent completion, prosecution and defense against well-capitalized competitors. These are serious risks and there is no assurance that our forward-looking statements will occur or prove to be accurate.



Executive Contact:
Marvin Maslow, CEO, Manhattan Scientifics (917) 923-3300.
Email: maslow@ix.netcom.com
Investor Relations Contact:
Frank Hawkins, (Hawk Associates) (305) 852-2383
Email: Info@hawkassociates.com

SOURCE Manhattan Scientifics


Marvin Maslow, CEO, Manhattan Scientifics, +1-917-923-3300, or
maslow@ix.netcom.com; or Investor Relations, Frank Hawkins, Hawk Associates,
+1-305-852-2383, or email, Info@hawkassociates.com, for Manhattan Scientifics
http://www.prnewswire.com


Posts: 71 | From: Nashville, TN, USA | Registered: Jan 2004  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2013 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share